Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rank in Stocks #15061
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Share Price
$4.66
Market Cap
$43.92M
Change (1 day)
-0.63%
Change (1 year)
338.04%
Country
FR
Trade Theranexus Société Anonyme (ALTHX)

Category

EPS for Theranexus Société Anonyme (ALTHX)
EPS as of December 2025 TTM: $-0.26
According to Theranexus Société Anonyme latest financial reports and stock price the company's current EPS (TTM) is $-0.26. At the end of 2023 the company had a EPS of $-0.97 a decrease compared to its 2022 EPS that were of $-1.33.
EPS history for Theranexus Société Anonyme from 2015 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.26 17.32%
2024 $-0.22 -77.54%
2023 $-0.97 -26.86%
2022 $-1.33 -29.54%
2021 $-1.89 31.35%
2020 $-1.44 -17.37%
2019 $-1.74 -10.98%
2018 $-1.95 139.44%
2017 $-0.82 -56.68%
2016 $-1.88 199.05%
2015 $-0.63 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$4.36 -1,788.61%
DK
$17.01 -6,690.47%
US
$42.53 -16,578.11%
US
$9.62 -3,827.55%
BE
$26.66 -10,429.33%
NL